Syngen Biotech Co.,Ltd. (TPEX:8279)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
98.60
-1.40 (-1.40%)
Apr 29, 2026, 1:30 PM CST

Syngen Biotech Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Net Income
243.83271.59240.21274.83321.24237.77
Upgrade
Depreciation & Amortization
118.68120.7114.4199.2986.3181.27
Upgrade
Other Amortization
0.630.630.270.180.190.13
Upgrade
Loss (Gain) From Sale of Assets
0.160.150.150.280.210.63
Upgrade
Asset Writedown & Restructuring Costs
0.40.4---1.81
Upgrade
Loss (Gain) From Sale of Investments
-0.3-0.30.49-0.02-0.21-0.98
Upgrade
Loss (Gain) on Equity Investments
-4.43-8.095.32-36.08-26.64-14.81
Upgrade
Provision & Write-off of Bad Debts
0.32-3.026.92-8.5817.820.33
Upgrade
Other Operating Activities
-20.231.36-5.3712.2436.6733.37
Upgrade
Change in Accounts Receivable
1.4-28.24-22.2990.02-101.12-13.1
Upgrade
Change in Inventory
-76.81-29.42-1.191.98-98.11-41.33
Upgrade
Change in Accounts Payable
157.7535.3525.820.49-62.1257.78
Upgrade
Change in Unearned Revenue
13.8812.334.813.310.184.58
Upgrade
Change in Other Net Operating Assets
-60.96-53.97-21.48-52.82103.07-10.94
Upgrade
Operating Cash Flow
374.32319.48348.04415.13277.48336.5
Upgrade
Operating Cash Flow Growth
1.65%-8.21%-16.16%49.60%-17.54%52.81%
Upgrade
Capital Expenditures
-49.98-63.56-60.21-91.9-584.27-61.67
Upgrade
Sale (Purchase) of Intangibles
-12.16-12.85-4.13-1.91-0.44-
Upgrade
Investment in Securities
---20---273.84
Upgrade
Other Investing Activities
9.24-0.41-0.190.12-0.33-0.57
Upgrade
Investing Cash Flow
-52.9-76.83-84.53-93.68-585.05-336.08
Upgrade
Short-Term Debt Issued
-25025028066050
Upgrade
Long-Term Debt Issued
---106.4913250
Upgrade
Total Debt Issued
190250250386.49792100
Upgrade
Short-Term Debt Repaid
--250-330-430-430-100
Upgrade
Long-Term Debt Repaid
--174.08-73.63-21.67-14.95-14.02
Upgrade
Total Debt Repaid
-373.4-424.08-403.63-451.67-444.95-114.02
Upgrade
Net Debt Issued (Repaid)
-183.4-174.08-153.63-65.17347.06-14.02
Upgrade
Common Dividends Paid
-135.5-135.5-135.5-135.5-108.4-94.85
Upgrade
Other Financing Activities
0.110.110.050.140.1-
Upgrade
Financing Cash Flow
-318.79-309.47-289.09-200.54238.75-108.88
Upgrade
Foreign Exchange Rate Adjustments
0.330.340.62-0.080.06-0.16
Upgrade
Net Cash Flow
2.96-66.47-24.96120.84-68.75-108.62
Upgrade
Free Cash Flow
324.34255.92287.83323.23-306.79274.83
Upgrade
Free Cash Flow Growth
4.46%-11.09%-10.95%---
Upgrade
Free Cash Flow Margin
15.69%11.98%14.29%17.59%-15.89%18.68%
Upgrade
Free Cash Flow Per Share
11.659.4310.6111.91-11.3110.13
Upgrade
Cash Interest Paid
5.745.749.358.844.893.2
Upgrade
Cash Income Tax Paid
62.8362.8386.6875.360.1528.87
Upgrade
Levered Free Cash Flow
262.28192.1200.8248.25-368.73240.8
Upgrade
Unlevered Free Cash Flow
265.43195.63206.6253.78-365.56242.8
Upgrade
Change in Working Capital
35.26-63.94-14.3672.99-158.11-3.02
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.